FDA inspection
InvaGen Pharmaceuticals, Inc.: FDA inspection ending Sep 19, 2023
FDA inspection 1218990 · Voluntary Action Indicated (VAI) · Central Islip, NY
Key facts
| Inspection ID | 1218990 |
|---|---|
| Firm | InvaGen Pharmaceuticals, Inc. |
| FEI number | 3012696190 |
| Address | 550 S Research Pl |
| City | Central Islip |
| State | NY |
| ZIP | 11722 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Sep 19, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data